AI Article Synopsis

  • * The research used both lab tests and computational methods to study the effects of UVB on crustaceans, focusing on a specific species to measure its impact at different biological levels.
  • * A novel network of quantitative adverse outcome pathways (qAOPs) was created using experimental data and existing information, providing a structured framework that could be useful for assessing both chemical and nonchemical stressors in the future.

Article Abstract

Ultraviolet B (UVB) radiation is a natural nonchemical stressor posing potential hazards to organisms such as planktonic crustaceans. The present study was conducted to revisit the lethal effects of UVB on crustaceans, generate new experimental evidence to fill in knowledge gaps, and develop novel quantitative adverse outcome pathways (qAOPs) for UVB. A combination of laboratory and computational approaches was deployed to achieve the goals. For targeted laboratory tests, was used as a prototype and exposed to a gradient of artificial UVB. Targeted bioassays were used to quantify the effects of UVB at multiple levels of biological organization. A toxicity pathway network was assembled based on the new experimental evidence and previously published data extracted using a novel computational tool, the NIVA Risk Assessment Database (NIVA RAdb). A network of AOPs was developed, and weight of evidence was assessed based on a combination of the current and existing data. In addition, quantitative key event relationships in the AOPs were developed by fitting the data to predefined models. A complete workflow for assembly and evaluation of qAOPs has been presented, which may serve as a good example for future de novo qAOP development for chemical and nonchemical stressors.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.est.0c03794DOI Listing

Publication Analysis

Top Keywords

quantitative adverse
8
adverse outcome
8
ultraviolet uvb
8
uvb radiation
8
targeted laboratory
8
laboratory tests
8
effects uvb
8
experimental evidence
8
aops developed
8
uvb
6

Similar Publications

PIM1 instigates endothelial-to-mesenchymal transition to aggravate atherosclerosis.

Theranostics

January 2025

Department of Neurosurgery, Qilu Hospital, Cheeloo College of Medicine and Institute of Brain and Brain-Inspired Science, Shandong University, Shandong, China.

Endothelial-to-mesenchymal transition (EndMT) is a cellular reprogramming mechanism by which endothelial cells acquire a mesenchymal phenotype. Endothelial cell dysfunction is the initiating factor of atherosclerosis (AS). Increasing evidence suggests that EndMT contributes to the occurrence and progression of atherosclerotic lesions and plaque instability.

View Article and Find Full Text PDF

Association between brominated flame retardants and periodontitis: a large-scale population-based study.

Front Public Health

January 2025

The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, China.

Background: The association between brominated flame retardants (BFRs) and periodontitis has remained unclear.

Methods: This research included adult participants from NHANES cycles 2009-2014. Survey-weighted generalized linear regressions were used to explore the associations between BFR exposure and periodontitis.

View Article and Find Full Text PDF

Background: Vascular inflammation persists in temporal artery biopsy (TAB) of giant cell arteritis (GCA) patients even after prolonged glucocorticoid (GC) therapy. We aimed to evaluate the histological impact of adding tocilizumab (TCZ) to GCs.

Methods: We enrolled all consecutive GCA patients with an inflammed TAB at diagnosis who were treated with TCZ and GCs for ≥6 months and followed from December 2017 to December 2023.

View Article and Find Full Text PDF

Objective: The dinoflagellate Alexandrium monilatum forms blooms during summer in tributaries of the lower Chesapeake Bay. Questions persist about the potential for A. monilatum to negatively affect aquatic organisms.

View Article and Find Full Text PDF

Structured medication reviews (SMRs) were introduced into the National Health Service (NHS) Primary Care to support the delivery of the NHS Long-Term Plan for medicines optimization. SMRs improve the quality of care, reduce harm and offer value for money. However, evidence to support SMRs for patients with chronic kidney disease (CKD) stage G4-5D with elevated risk of cardiovascular disease and premature mortality is unknown.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!